- AZN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
SC 13G Filing
AstraZeneca (AZN) SC 13GMonopar Therapeutics / ASTRAZENECA ownership change
Filed: 28 Oct 24, 6:00am
EXHIBIT A
Agreement of Joint Filing
The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock of Monopar Therapeutics Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
AstraZeneca PLC | ||
Dated: October 28, 2024 | By: | /s/ Adrian Kemp |
Adrian Kemp | ||
Company Secretary |
Alexion Pharmaceuticals, Inc. | ||
Dated: October 28, 2024 | By: | /s/ Todd Spalding |
Todd Spalding | ||
Secretary |
Page 1 of 1 Pages
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.